Clinical trial • Phase III • Neurology|Musculoskeletal

Ocrelizumab for Multiple sclerosis

Phase III trial of Ocrelizumab for Multiple sclerosis. open-label. 1110 participants.

Overview

Trial Therapeutic Area
Neurology|Musculoskeletal
Trial Disease
Multiple sclerosis
Trial Stage
Phase III
Drug Modality
Monoclonal antibody

Key dates

Initial CTIS Submission Date
05-06-2024
First CTIS Authorization Date
08-07-2024

Trial design

open-label Phase III trial in Slovakia, Latvia, Romania and others.

Open Label
Yes
Target Sample Size
1110

Eligibility

Recruits 1110 Vulnerable population selected. Study submission includes infant/child-related documentation (e.g. documents titled 'L1_SIS and ICF Infant Authorization Form', 'L2_Other subject information material_Infant Health Questionnaire', 'L1_SIS and ICF_Baby Health Information'), indicating provision of infant/child information and authorization forms..

Pregnancy Exclusion
For female participants of childbearing potential: agreement to remain abstinent (refrain from heterosexual intercourse) or use adequate acceptable contraception during the treatment period and for at least 6 months or longer if the local label is more stringent after the final dose of ocrelizumab, as applicable in the ocrelizumab package leaflet
Vulnerable Population
Vulnerable population selected. Study submission includes infant/child-related documentation (e.g. documents titled 'L1_SIS and ICF Infant Authorization Form', 'L2_Other subject information material_Infant Health Questionnaire', 'L1_SIS and ICF_Baby Health Information'), indicating provision of infant/child information and authorization forms.

Inclusion criteria

  • {"criterion_text":"- Prior eligibility for and previous participation in 1 of the Roche-sponsored Parent Studies WA21092, WA21093, or WA25046 with the participant either receiving ocrelizumab as an investigational medicinal product (IMP) or being in safety follow-up after treatment discontinuation"}
  • {"criterion_text":"- For female participants of childbearing potential: agreement to remain abstinent (refrain from heterosexual intercourse) or use adequate acceptable contraception during the treatment period and for at least 6 months or longer if the local label is more stringent after the final dose of ocrelizumab, as applicable in the ocrelizumab package leaflet"}

Exclusion criteria

  • {"criterion_text":"- Concurrent participation in any clinical trial (other than the Parent study)"}
  • {"criterion_text":"- Unable or unwilling to comply with the requirements of the protocol"}

Endpoints

Primary endpoints

  • {"endpoint_text":"- 1. Incidence and severity of adverse events, with severity determined according to the National Cancer Institute Common Terminology Criteria for Adverse Events version 5.0 (NCI CTCAE v5.0)","definition_or_measurement_approach":"Severity determined according to NCI CTCAE v5.0"}

Secondary endpoints

  • {"endpoint_text":"- 1. Change in Expanded Disability Status Scale (EDSS) score over time","definition_or_measurement_approach":"Change in EDSS score measured over time (EDSS instrument)"}
  • {"endpoint_text":"- 2. Change in 9-Hole Peg Test (9HPT) and Timed 25-Foot Walk Test (T25FWT) over time","definition_or_measurement_approach":"Change over time in 9HPT and T25FWT performance measures"}
  • {"endpoint_text":"- 3. The number of new, hypointense T1 lesions and number of new or enlarging T2 lesions","definition_or_measurement_approach":"MRI lesion counts: new hypointense T1 lesions and new/enlarging T2 lesions"}
  • {"endpoint_text":"- 4. The change in total volume of T2 lesions and in total T1 lesion volume","definition_or_measurement_approach":"Change in MRI measured total T2 lesion volume and total T1 lesion volume"}

Recruitment

Planned Sample Size
1110
Recruitment Window Months
43
Consent Approach
Participant information sheets and informed consent forms (ICFs) are provided; infant/authorization forms are included where relevant (e.g. 'Infant Authorization Form', 'Infant Health Questionnaire', 'Baby Health Information'). ICFs and related materials are submitted in multiple country/language versions (examples in the submission include English, Latvian, Russian, Romanian, French, Spanish, Italian, Dutch, Hungarian, Polish, Swedish, Portuguese, Lithuanian), indicating country-specific language materials and specific infant/authorization documentation.

Geography

Total Number Of Sites
105
Total Number Of Participants
809

Slovakia

Earliest CTIS Part Ii Submission Date
20-06-2024
Latest Decision Or Authorization Date
08-07-2024
Processing Time Days
18
Number Of Sites
3
Number Of Participants
12

Sites

Site Name
MUDr. Beata Dupejova neurologicka ambulancia s.r.o.
Department Name
Neurologicka ambulancia
Principal Investigator Name
Beata Dupejova
Principal Investigator Email
dupejova@gmail.com
Contact Person Name
Beata Dupejova
Contact Person Email
dupejova@gmail.com
Site Name
Fakultna Nemocnica S Poliklinikou Zilina
Department Name
Neurologicke oddelenie
Principal Investigator Name
Juraj Vyletelka
Principal Investigator Email
vyletelka@nextra.sk
Contact Person Name
Juraj Vyletelka
Contact Person Email
vyletelka@nextra.sk
Site Name
University Hospital Bratislava
Department Name
Neurologicka klinika SZU a UNB
Principal Investigator Name
Viera Hancinova
Principal Investigator Email
dr.hancinova@gmail.com
Contact Person Name
Viera Hancinova
Contact Person Email
dr.hancinova@gmail.com

Latvia

Earliest CTIS Part Ii Submission Date
20-06-2024
Latest Decision Or Authorization Date
08-07-2024
Processing Time Days
18
Number Of Sites
2
Number Of Participants
6

Sites

Site Name
Latvijas Juras medicinas centrs AS
Department Name
Neurology
Principal Investigator Name
Jolanta Kalnina
Principal Investigator Email
jolanta@ljmc.lv
Contact Person Name
Jolanta Kalnina
Contact Person Email
jolanta@ljmc.lv
Site Name
Pauls Stradins Clinical University Hospital
Department Name
Neurology
Principal Investigator Name
Alina Flintere-Flinte
Principal Investigator Email
alina-medi@inbox.lv
Contact Person Name
Alina Flintere-Flinte
Contact Person Email
alina-medi@inbox.lv

Romania

Earliest CTIS Part Ii Submission Date
20-06-2024
Latest Decision Or Authorization Date
11-07-2024
Processing Time Days
21
Number Of Sites
1
Number Of Participants
1

Sites

Site Name
Clubul Sanatatii S.R.L.
Department Name
Compartiment Cercetare, Secţia de Neurologie
Principal Investigator Name
Emilian-Silviu Manescu
Principal Investigator Email
silviumanescu@yahoo.com
Contact Person Name
Emilian-Silviu Manescu
Contact Person Email
silviumanescu@yahoo.com

Bulgaria

Earliest CTIS Part Ii Submission Date
20-06-2024
Latest Decision Or Authorization Date
08-07-2024
Processing Time Days
18
Number Of Sites
7
Number Of Participants
25

Sites

Site Name
Tokuda Hospital
Department Name
Clinic of Neurology and Sleep Medicine
Principal Investigator Name
Ivan Staikov
Principal Investigator Email
ivanstaikov@hotmail.com
Contact Person Name
Ivan Staikov
Contact Person Email
ivanstaikov@hotmail.com
Site Name
Universitetska Parva Mnogoprofilna Bolnitsa Za Aktivno Lechenie Sofia Sv. Yoan Krastitel
Department Name
Clinic of Neurology
Principal Investigator Name
Dimitar Maslarov
Principal Investigator Email
maslarovdb@abv.bg
Contact Person Name
Dimitar Maslarov
Contact Person Email
maslarovdb@abv.bg
Site Name
MHAT National Heart Hospital EAD
Department Name
Clinic of Neurology
Principal Investigator Name
Lyubomir Haralanov
Principal Investigator Email
haralanovl@yahoo.com
Contact Person Name
Lyubomir Haralanov
Contact Person Email
haralanovl@yahoo.com
Site Name
Multiprofile Hospital For Active Treatment In Neurology And Psychiatry St. Naum EAD
Department Name
Clinic of neurology diseases for movement disorders
Principal Investigator Name
Sonya Hristova-Chakmakova
Principal Investigator Email
ivanovasonia@gmail.com
Contact Person Name
Sonya Hristova-Chakmakova
Contact Person Email
ivanovasonia@gmail.com
Site Name
Military Medical Academy
Department Name
Clinic of Neurology
Principal Investigator Name
Hristina Dimitrova
Principal Investigator Email
drhrisi@abv.bg
Contact Person Name
Hristina Dimitrova
Contact Person Email
drhrisi@abv.bg
Site Name
Multiprofile Hospital For Active Treatment In Neurology And Psychiatry St. Naum EAD
Department Name
Clinic for intensive treatment of neurology diseases
Principal Investigator Name
Milena Milanova
Principal Investigator Email
milanova_m@dir.bg
Contact Person Name
Milena Milanova
Contact Person Email
milanova_m@dir.bg
Site Name
Multiprofile Hospital For Active Treatment Avis Medika OOD
Department Name
Department of Neurology
Principal Investigator Name
Hristo Lilovski
Principal Investigator Email
hristolilovski@gmail.com
Contact Person Name
Hristo Lilovski
Contact Person Email
hristolilovski@gmail.com

Croatia

Earliest CTIS Part Ii Submission Date
20-06-2024
Latest Decision Or Authorization Date
09-07-2024
Processing Time Days
19
Number Of Sites
2
Number Of Participants
14

Sites

Site Name
KBC Zagreb
Department Name
Neurology
Principal Investigator Name
Mario Habek
Principal Investigator Email
mario.habek@mef.hr
Contact Person Name
Mario Habek
Contact Person Email
mario.habek@mef.hr
Site Name
Opca Bolnica Varazdin
Department Name
Neurology
Principal Investigator Name
Spomenka Kidjemet-Piskac
Principal Investigator Email
spiskac@gmail.com
Contact Person Name
Spomenka Kidjemet-Piskac
Contact Person Email
spiskac@gmail.com

Spain

Earliest CTIS Part Ii Submission Date
20-06-2024
Latest Decision Or Authorization Date
11-07-2024
Processing Time Days
21
Number Of Sites
11
Number Of Participants
78

Sites

Site Name
Complexo Hospitalario Universitario De Santiago
Department Name
Neurology
Principal Investigator Name
José María Prieto González
Principal Investigator Email
josemaoscar.prieto@usc.es
Contact Person Name
José María Prieto González
Contact Person Email
josemaoscar.prieto@usc.es
Site Name
Hospital Universitario Ramon Y Cajal
Department Name
Neurology
Principal Investigator Name
Lucienne Costa-Frossard Franca
Principal Investigator Email
lufrossard@yahoo.es
Contact Person Name
Lucienne Costa-Frossard Franca
Contact Person Email
lufrossard@yahoo.es
Site Name
Hospital Santa Caterina Ias
Department Name
Neurology
Principal Investigator Name
Gary Alvarez Bravo
Principal Investigator Email
garinho29@icloud.com
Contact Person Name
Gary Alvarez Bravo
Contact Person Email
garinho29@icloud.com
Site Name
Hospital Universitario Puerta De Hierro De Majadahonda
Department Name
Neurology
Principal Investigator Name
Julia Sabin Muñon
Principal Investigator Email
julia.sabin.m@gmail.com
Contact Person Name
Julia Sabin Muñon
Contact Person Email
julia.sabin.m@gmail.com
Site Name
Hospital Universitario De La Princesa
Department Name
Neurology
Principal Investigator Name
Virginia Meca Lallana
Principal Investigator Email
virmeca@hotmail.com
Contact Person Name
Virginia Meca Lallana
Contact Person Email
virmeca@hotmail.com
Site Name
Hospital Clinico San Carlos
Department Name
Neurology
Principal Investigator Name
Celia Oreja Guevara
Principal Investigator Email
orejacbn@gmail.com
Contact Person Name
Celia Oreja Guevara
Contact Person Email
orejacbn@gmail.com
Site Name
Hospital Universitari Vall D Hebron
Department Name
Neurology
Principal Investigator Name
Xavier Montalban Gairin
Principal Investigator Email
xavier.montalban@cem-cat.org
Contact Person Name
Xavier Montalban Gairin
Contact Person Email
xavier.montalban@cem-cat.org
Site Name
Bellvitge University Hospital
Department Name
Neurology
Principal Investigator Name
Sergio Martínez Yelamos
Principal Investigator Email
smartinezy@bellvitgehospital.cat
Contact Person Name
Sergio Martínez Yelamos
Site Name
Hospital Universitario Basurto
Department Name
Neurology
Principal Investigator Name
Cristina Llarena González
Contact Person Name
Cristina Llarena González
Site Name
Hospital Universitario Regional De Malaga
Department Name
Neurology
Principal Investigator Name
Ana María Alonso Torres
Principal Investigator Email
a.alonso.eecc@gmail.com
Contact Person Name
Ana María Alonso Torres
Contact Person Email
a.alonso.eecc@gmail.com
Site Name
Hospital Universitario Virgen De La Macarena
Department Name
Neurology
Principal Investigator Name
Sara Eichau Madueno
Principal Investigator Email
saraeichau@gmail.com
Contact Person Name
Sara Eichau Madueno
Contact Person Email
saraeichau@gmail.com

Sweden

Earliest CTIS Part Ii Submission Date
20-06-2024
Latest Decision Or Authorization Date
09-07-2024
Processing Time Days
19
Number Of Sites
3
Number Of Participants
9

Sites

Site Name
Sahlgrenska University Hospital-Vaestra Goetalandsregionen
Department Name
Department of Neurology
Principal Investigator Name
Clas Malmeström
Principal Investigator Email
jan.lycke@neuro.gu.se
Contact Person Name
Clas Malmeström
Contact Person Email
jan.lycke@neuro.gu.se
Site Name
Karolinska University Hospital
Department Name
Department of Clinical Neuroscience
Principal Investigator Name
Virginija Karrenbauer
Principal Investigator Email
virginija.karrenbauer@ki.se
Contact Person Name
Virginija Karrenbauer
Contact Person Email
virginija.karrenbauer@ki.se
Site Name
Region Stockholm – SLSO
Department Name
Department of Neurology
Principal Investigator Name
Tomas Olsson
Principal Investigator Email
tomas.olsson@ki.se
Contact Person Name
Tomas Olsson
Contact Person Email
tomas.olsson@ki.se

Belgium

Earliest CTIS Part Ii Submission Date
20-06-2024
Latest Decision Or Authorization Date
10-07-2024
Processing Time Days
20
Number Of Sites
5
Number Of Participants
21

Sites

Site Name
Cliniques Universitaires Saint-Luc
Department Name
Neurology
Principal Investigator Name
Vincent Van Pesh
Principal Investigator Email
vincent.vanpesch@saintluc.uclouvain.be
Contact Person Name
Vincent Van Pesh
Site Name
Algemeen Ziekenhuis Delta
Department Name
Neurology
Principal Investigator Name
Maarten Buyle
Principal Investigator Email
maarten.buyle@azdelta.be
Contact Person Name
Maarten Buyle
Contact Person Email
maarten.buyle@azdelta.be
Site Name
Algemeen Ziekenhuis Alma
Department Name
Neurology
Principal Investigator Name
Danny Decoo
Principal Investigator Email
danny.decoo@azalma.be
Contact Person Name
Danny Decoo
Contact Person Email
danny.decoo@azalma.be
Site Name
Az St-Jan Brugge-Oostende A.V.
Department Name
Neurology
Principal Investigator Name
Melissa Cambron
Principal Investigator Email
melissa.cambron@azsintjan.be
Contact Person Name
Melissa Cambron
Contact Person Email
melissa.cambron@azsintjan.be
Site Name
Antwerp University Hospital
Department Name
Neurology
Principal Investigator Name
Barbara Willekens
Principal Investigator Email
barbara.willekens@uza.be
Contact Person Name
Barbara Willekens
Contact Person Email
barbara.willekens@uza.be

France

Earliest CTIS Part Ii Submission Date
20-06-2024
Latest Decision Or Authorization Date
12-07-2024
Processing Time Days
22
Number Of Sites
10
Number Of Participants
40

Sites

Site Name
University Hospital Of Clermont-Ferrand
Department Name
Service de neurologie
Principal Investigator Name
Pierre CLAVELOU
Principal Investigator Email
pclavelou@chu-clermontferrand.fr
Contact Person Name
Pierre CLAVELOU
Site Name
Centre Hospitalier Universitaire De Bordeaux
Department Name
Service de neurologie
Principal Investigator Name
Aurélie RUET
Principal Investigator Email
aurelie.ruet@chu-bordeaux.fr
Contact Person Name
Aurélie RUET
Contact Person Email
aurelie.ruet@chu-bordeaux.fr
Site Name
Centre Hospitalier Intercommunal De Poissy Saint Germain
Department Name
Service de neurologie
Principal Investigator Name
Olivier HEINZLEF
Principal Investigator Email
olivier.heinzlef@ght-yvelinesnord.fr
Contact Person Name
Olivier HEINZLEF
Site Name
Les Hopitaux Universitaires De Strasbourg
Department Name
Service de neurologie
Principal Investigator Name
Jerome DE SEZE
Principal Investigator Email
jerome.deseze@chru-strasbourg.fr
Contact Person Name
Jerome DE SEZE
Site Name
CHRU De Nancy
Department Name
Service de neurologie
Principal Investigator Name
Guillaume MATHEY
Principal Investigator Email
g.mathey@chru-nancy.fr
Contact Person Name
Guillaume MATHEY
Contact Person Email
g.mathey@chru-nancy.fr
Site Name
Centre Hospitalier Universitaire De Lille
Department Name
Service de neurologie D
Principal Investigator Name
Patrick VERMERSCH
Principal Investigator Email
patrick.vermersch@univ-lille.fr
Contact Person Name
Patrick VERMERSCH
Site Name
Centre Hospitalier Universitaire De Nantes
Department Name
Service de neurologie, CIC de neurologie
Principal Investigator Name
David LAPLAUD
Principal Investigator Email
david.laplaud@univ-nantes.fr
Contact Person Name
David LAPLAUD
Contact Person Email
david.laplaud@univ-nantes.fr
Site Name
Centre Hospitalier Universitaire De Caen Normandie
Department Name
Service de neurologie
Principal Investigator Name
Pierre BRANGER
Principal Investigator Email
branger-p@chu-caen.fr
Contact Person Name
Pierre BRANGER
Contact Person Email
branger-p@chu-caen.fr
Site Name
Hospital Pierre Wertheimer
Department Name
Service de neurologie, sclérose en plaques, pathologies de la myéline et neuroinflammation
Principal Investigator Name
Sandra VUKUSIC
Principal Investigator Email
sandra.vukusic@chu-lyon.fr
Contact Person Name
Sandra VUKUSIC
Contact Person Email
sandra.vukusic@chu-lyon.fr
Site Name
Centre Hospitalier Universitaire De Nice
Department Name
Services des neurosciences
Principal Investigator Name
Christine LEBRUN FRENAY
Principal Investigator Email
lebrun-frenay.c@chu-nice.fr
Contact Person Name
Christine LEBRUN FRENAY
Contact Person Email
lebrun-frenay.c@chu-nice.fr

Portugal

Earliest CTIS Part Ii Submission Date
20-06-2024
Latest Decision Or Authorization Date
10-07-2024
Processing Time Days
20
Number Of Sites
4
Number Of Participants
10

Sites

Site Name
Unidade Local De Saude De Almada-Seixal E.P.E.
Department Name
Neurologia
Principal Investigator Name
Maria Irene Mendes
Principal Investigator Email
maria.irene.mendes@hgo.min-saude.pt
Contact Person Name
Maria Irene Mendes
Site Name
Unidade Local De Saude De Coimbra E.P.E.
Department Name
Neurologia
Principal Investigator Name
Carla Cecilia Nunes
Principal Investigator Email
carlacecilianunes@gmail.com
Contact Person Name
Carla Cecilia Nunes
Contact Person Email
carlacecilianunes@gmail.com
Site Name
Unidade Local De Saude De Santa Maria E.P.E.
Department Name
Neurologia
Principal Investigator Name
João Ferreira
Principal Investigator Email
jnuno.d.ferreira@gmail.com
Contact Person Name
João Ferreira
Contact Person Email
jnuno.d.ferreira@gmail.com
Site Name
CCAB Centro Clinico Academico Braga Associacao
Department Name
Neurologia
Principal Investigator Name
João José Cerqueira
Principal Investigator Email
jcerqueira@med.uminho.pt
Contact Person Name
João José Cerqueira
Contact Person Email
jcerqueira@med.uminho.pt

Estonia

Earliest CTIS Part Ii Submission Date
20-06-2024
Latest Decision Or Authorization Date
19-07-2024
Processing Time Days
29
Number Of Sites
2
Number Of Participants
7

Sites

Site Name
Laane-Tallinna Keskhaigla AS
Department Name
Neurology
Principal Investigator Name
Katrin Gross-Paju
Principal Investigator Email
katrin.gross-paju@keskhaigla.ee
Contact Person Name
Katrin Gross-Paju
Site Name
Tartu University Hospital
Department Name
Neurology
Principal Investigator Name
Irja Kalbe
Principal Investigator Email
irja.kalbe@kliinikum.ee
Contact Person Name
Irja Kalbe
Contact Person Email
irja.kalbe@kliinikum.ee

Czechia

Earliest CTIS Part Ii Submission Date
20-06-2024
Latest Decision Or Authorization Date
10-07-2024
Processing Time Days
20
Number Of Sites
7
Number Of Participants
83

Sites

Site Name
Krajska zdravotni a.s.
Department Name
Neurology
Principal Investigator Name
Marta Vachová
Principal Investigator Email
marta.vachova@kzcr.eu
Contact Person Name
Marta Vachová
Contact Person Email
marta.vachova@kzcr.eu
Site Name
Fakultni Nemocnice U Sv Anny V Brne
Department Name
Neurology
Principal Investigator Name
Michal Dufek
Principal Investigator Email
michal.dufek@fnusa.cz
Contact Person Name
Michal Dufek
Contact Person Email
michal.dufek@fnusa.cz
Site Name
Fakultni Nemocnice Hradec Kralove
Department Name
Neurology
Principal Investigator Name
Zbyšek Pavelek
Principal Investigator Email
zbysekpavelekr@email.cz
Contact Person Name
Zbyšek Pavelek
Contact Person Email
zbysekpavelekr@email.cz
Site Name
Vseobecna Fakultni Nemocnice V Praze
Department Name
Neurology
Principal Investigator Name
Eva Kubala Havrdová
Principal Investigator Email
eva.kubalahavrdova@vfn.cz
Contact Person Name
Eva Kubala Havrdová
Contact Person Email
eva.kubalahavrdova@vfn.cz
Site Name
Nemocnice Jihlava prispevkova organizace
Department Name
Neurology
Principal Investigator Name
Ondřej Škoda
Principal Investigator Email
skodao@nemji.cz
Contact Person Name
Ondřej Škoda
Contact Person Email
skodao@nemji.cz
Site Name
Neurospol s.r.o.
Department Name
Neurology
Principal Investigator Name
Pavel Hradílek
Principal Investigator Email
pavel.hradilek@seznam.cz
Contact Person Name
Pavel Hradílek
Contact Person Email
pavel.hradilek@seznam.cz
Site Name
Fakultni Nemocnice Brno
Department Name
Neurology
Principal Investigator Name
Yvonne Benešová
Principal Investigator Email
benesova.yvonne@fnbrno.cz
Contact Person Name
Yvonne Benešová
Contact Person Email
benesova.yvonne@fnbrno.cz

Poland

Earliest CTIS Part Ii Submission Date
20-06-2024
Latest Decision Or Authorization Date
15-07-2024
Processing Time Days
25
Number Of Sites
12
Number Of Participants
170

Sites

Site Name
Neuroprotect Sp. z o.o.
Principal Investigator Name
Maciej Czarnecki
Principal Investigator Email
maciej.czarnecki@neuroprotect.pl
Contact Person Name
Maciej Czarnecki
Site Name
Centrum Neurologii Krzysztof Selmaj
Principal Investigator Name
Krzysztof Selmaj
Principal Investigator Email
kselmaj@gmail.com
Contact Person Name
Krzysztof Selmaj
Contact Person Email
kselmaj@gmail.com
Site Name
Vitamed Galaj I Cichomski Sp. j.
Principal Investigator Name
Maciej Binek
Principal Investigator Email
binek.maciej@wp.pl
Contact Person Name
Maciej Binek
Contact Person Email
binek.maciej@wp.pl
Site Name
Copernicus Podmiot Leczniczy Sp. z o.o.
Department Name
Oddział Neurologiczny
Principal Investigator Name
Waldemar Fryze
Principal Investigator Email
w.fryze@wp.pl
Contact Person Name
Waldemar Fryze
Contact Person Email
w.fryze@wp.pl
Site Name
Uniwersytecki Szpital Kliniczny Nr 4 W Lublinie
Department Name
Kliniczny Oddział Neurologii Oddział Udarowy i Wczesnej Rehabilitacji Poudarowej
Principal Investigator Name
Konrad Rejdak
Principal Investigator Email
rejdakk@gmail.com
Contact Person Name
Konrad Rejdak
Contact Person Email
rejdakk@gmail.com
Site Name
Neuro-Medic Sp. z o.o.
Principal Investigator Name
Janusz Zbrojkiewicz
Principal Investigator Email
jzbrojkiewicz@op.pl
Contact Person Name
Janusz Zbrojkiewicz
Contact Person Email
jzbrojkiewicz@op.pl
Site Name
Specjalistyczna Praktyka Lekarska prof. Grzegorz Opala
Principal Investigator Name
Grzegorz Opala
Principal Investigator Email
opala.praktyka@gmail.com
Contact Person Name
Grzegorz Opala
Contact Person Email
opala.praktyka@gmail.com
Site Name
Neuro-Care Sp. z o.o. sp.k.
Principal Investigator Name
Gabriela Kłodowska
Principal Investigator Email
g.klodowska@neuro-care.pl
Contact Person Name
Gabriela Kłodowska
Contact Person Email
g.klodowska@neuro-care.pl
Site Name
Krakowska Akademia Neurologii Sp. z o.o.
Principal Investigator Name
Andrzej Szczudlik
Principal Investigator Email
andrzej.szczudlik@neurologia.org.pl
Contact Person Name
Andrzej Szczudlik
Site Name
Wojewodzki Szpital Specjalistyczny W Olsztynie
Department Name
Oddział Neurologiczny
Principal Investigator Name
Andrzej Tutaj
Principal Investigator Email
tutajandrzej@poczta.onet.pl
Contact Person Name
Andrzej Tutaj
Contact Person Email
tutajandrzej@poczta.onet.pl
Site Name
Ma-Lek Clinical Sp. z o.o.
Principal Investigator Name
Maciej Maciejowski
Principal Investigator Email
m.m@ctsm.pl
Contact Person Name
Maciej Maciejowski
Contact Person Email
m.m@ctsm.pl
Site Name
Neurologiczny NZOZ Centrum Leczenia SM Ośrodek Badań Klinicznych im. dr n. med. Hanki Hertmanowskiej
Principal Investigator Name
Adriana Chełminiak
Principal Investigator Email
ada-neta@wp.pl
Contact Person Name
Adriana Chełminiak
Contact Person Email
ada-neta@wp.pl

Lithuania

Earliest CTIS Part Ii Submission Date
20-06-2024
Latest Decision Or Authorization Date
23-07-2024
Processing Time Days
33
Number Of Sites
2
Number Of Participants
9

Sites

Site Name
Vilniaus Universiteto Ligonine Santaros Klinikos Vsi
Department Name
Department of Neurology
Principal Investigator Name
Kizlaitiene Rasa
Principal Investigator Email
rasa.kizlaitiene@santa.lt
Contact Person Name
Kizlaitiene Rasa
Contact Person Email
rasa.kizlaitiene@santa.lt
Site Name
Lietuvos sveikatos mokslu universiteto ligonine Kauno klinikos
Department Name
Department of Neurology
Principal Investigator Name
Antanas Vaitkus
Principal Investigator Email
antanas.vaitkus@kaunoklinikos.lt
Contact Person Name
Antanas Vaitkus

Italy

Earliest CTIS Part Ii Submission Date
20-06-2024
Latest Decision Or Authorization Date
05-08-2024
Processing Time Days
46
Number Of Sites
11
Number Of Participants
103

Sites

Site Name
Ospedale San Raffaele S.r.l.
Department Name
Neurology
Principal Investigator Name
Massimo Filippi
Principal Investigator Email
filippi.massimo@hsr.it
Contact Person Name
Massimo Filippi
Contact Person Email
filippi.massimo@hsr.it
Site Name
Azienda Ospedaliero-Universitaria San Luigi Gonzaga
Department Name
Neurology
Principal Investigator Name
Simona Malucchi
Principal Investigator Email
s.malucchi@sanluigi.piemonte.it
Contact Person Name
Simona Malucchi
Site Name
Azienda Ospedaliera Policlinico Universitario Tor Vergata
Department Name
Neurology
Principal Investigator Name
Alessandra Girolama Marfia
Principal Investigator Email
marfia@uniroma2.it
Contact Person Name
Alessandra Girolama Marfia
Contact Person Email
marfia@uniroma2.it
Site Name
IRCCS Ospedale Policlinico San Martino
Department Name
Neurology
Principal Investigator Name
Antonio Uccelli
Principal Investigator Email
auccelli@neurologia.unige.it
Contact Person Name
Antonio Uccelli
Contact Person Email
auccelli@neurologia.unige.it
Site Name
Azienda Socio Sanitaria Territoriale Della Valle Olona
Department Name
Neurology
Principal Investigator Name
Pietro Annovazzi
Principal Investigator Email
pietro.annovazzi@gmail.com
Contact Person Name
Pietro Annovazzi
Contact Person Email
pietro.annovazzi@gmail.com
Site Name
Azienda Sanitaria Locale Della Provincia Di Biella
Department Name
Neurology
Principal Investigator Name
Graziano Gusmaroli
Principal Investigator Email
graziano.gusmaroli@aslbi.piemonte.it
Contact Person Name
Graziano Gusmaroli
Site Name
Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia
Department Name
Neurology
Principal Investigator Name
Cinzia Cordioli
Principal Investigator Email
cinzia.cordioli@gmail.com
Contact Person Name
Cinzia Cordioli
Contact Person Email
cinzia.cordioli@gmail.com
Site Name
Azienda Ospedaliero-Universitaria Delle Marche
Department Name
Neurology
Principal Investigator Name
Raffaella Cerqua
Principal Investigator Email
raffaella.cerqua@ospedaliriuniti.marche.it
Contact Person Name
Raffaella Cerqua
Site Name
Fondazione Istituto G. Giglio Di Cafalu
Department Name
Neurology
Principal Investigator Name
Luigi Grimaldi
Principal Investigator Email
luigi.grimaldi@hsrgiglio.it
Contact Person Name
Luigi Grimaldi
Contact Person Email
luigi.grimaldi@hsrgiglio.it
Site Name
IRCCS Foundation Istituto Neurologico Carlo Besta
Department Name
Neurology
Principal Investigator Name
Carlo Giuseppe Antozzi
Principal Investigator Email
carlo.antozzi@istituto-besta.it
Contact Person Name
Carlo Giuseppe Antozzi
Site Name
Azienda Ospedaliero-Universitaria Sant Andre
Department Name
Neurology
Principal Investigator Name
Giovanni Ristori
Principal Investigator Email
giovanni.ristori@uniroma1.it
Contact Person Name
Giovanni Ristori
Contact Person Email
giovanni.ristori@uniroma1.it

Finland

Earliest CTIS Part Ii Submission Date
20-06-2024
Latest Decision Or Authorization Date
08-07-2024
Processing Time Days
18
Number Of Sites
1
Number Of Participants
1

Sites

Site Name
Suomen Terveystalo Oy
Department Name
Terveystalo Tampere
Principal Investigator Name
Marja-Liisa Sumelahti
Principal Investigator Email
marja-liisa.sumelahti@terveystalo.com
Contact Person Name
Marja-Liisa Sumelahti

Hungary

Earliest CTIS Part Ii Submission Date
20-06-2024
Latest Decision Or Authorization Date
08-07-2024
Processing Time Days
18
Number Of Sites
3
Number Of Participants
20

Sites

Site Name
University Of Pecs
Department Name
Neurológiai Klinika
Principal Investigator Name
Péter Ács
Principal Investigator Email
acspeterdr@gmail.com
Contact Person Name
Péter Ács
Contact Person Email
acspeterdr@gmail.com
Site Name
S-Medicon Egészségügyi Szolgáltató Kft.
Department Name
Neurológia
Principal Investigator Name
Mária Sátori
Principal Investigator Email
satori.maria@gmail.com
Contact Person Name
Mária Sátori
Contact Person Email
satori.maria@gmail.com
Site Name
Jahn Ferenc Del-Pesti Korhaz Es Rendelointezet
Department Name
Neurológiai Osztály
Principal Investigator Name
Csilla Rózsa
Principal Investigator Email
rozsa.csilla@delpestikorhaz.hu
Contact Person Name
Csilla Rózsa
Contact Person Email
rozsa.csilla@delpestikorhaz.hu

Germany

Earliest CTIS Part Ii Submission Date
20-06-2024
Latest Decision Or Authorization Date
12-07-2024
Processing Time Days
22
Number Of Sites
15
Number Of Participants
184

Sites

Site Name
Universitaetsklinikum Ulm AöR
Department Name
Klinik fuer Neurologie
Principal Investigator Name
Hayrettin Tumani
Principal Investigator Email
hayrettin.tumani@uni-ulm.de
Contact Person Name
Hayrettin Tumani
Contact Person Email
hayrettin.tumani@uni-ulm.de
Site Name
Juedisches Krankenhaus Berlin Stiftung Des Buergerlichen Rechts
Department Name
Klinik fuer Neurologie
Principal Investigator Name
Juliane Klehmet
Principal Investigator Email
juliane.klehmet@jkb-online.de
Contact Person Name
Juliane Klehmet
Contact Person Email
juliane.klehmet@jkb-online.de
Site Name
Universitaet Leipzig
Department Name
Klinik und Poliklinik fuer Neurologie
Principal Investigator Name
Florian Then Bergh
Principal Investigator Email
florian.thenbergh@medizin.uni-leipzig.de
Contact Person Name
Florian Then Bergh
Site Name
Universitaetsklinikum Duesseldorf AöR
Department Name
Klinik fuer Neurologie
Principal Investigator Name
Norbert Goebels
Principal Investigator Email
norbert.goebels@med.uni-duesseldorf.de
Contact Person Name
Norbert Goebels
Site Name
Charite Universitaetsmedizin Berlin KöR
Department Name
Neurology
Principal Investigator Name
Carolin Otto
Principal Investigator Email
carolin.otto@charite.de
Contact Person Name
Carolin Otto
Contact Person Email
carolin.otto@charite.de
Site Name
Neurologie in Bonn
Department Name
Neurologie
Principal Investigator Name
Stephan Schmidt
Principal Investigator Email
schmidt@neurologie-in-bonn.de
Contact Person Name
Stephan Schmidt
Contact Person Email
schmidt@neurologie-in-bonn.de
Site Name
Universitaetsklinikum Tuebingen AöR
Department Name
Abteilung fuer Neurodegenerative Erkrankungen
Principal Investigator Name
Ulf Ziemann
Principal Investigator Email
ulf.ziemann@med.uni-tuebingen.de
Contact Person Name
Ulf Ziemann
Site Name
Universitaetsklinikum Carl Gustav Carus Dresden an der Technischen Universitaet Dresden AöR
Department Name
Klinik und Poliklinik fuer Neurologie
Principal Investigator Name
Tjalf Ziemssen
Principal Investigator Email
tjalf.ziemssen@ukdd.de
Contact Person Name
Tjalf Ziemssen
Contact Person Email
tjalf.ziemssen@ukdd.de
Site Name
Pharmakologisches Studienzentrum Chemnitz GmbH
Principal Investigator Name
Ralf Bodenschatz
Contact Person Name
Ralf Bodenschatz
Site Name
Universitaetsklinikum Muenster AöR
Department Name
Klinik f. Neurologie mit Institut f.Transl. Neurol
Principal Investigator Name
Luisa Koltz
Principal Investigator Email
luisa.klotz@ukmuenster.de
Contact Person Name
Luisa Koltz
Contact Person Email
luisa.klotz@ukmuenster.de
Site Name
NeuroPoint Gesellschaft fur vorbeugende Gesundheitspflege GmbH
Department Name
Studienzentrum
Principal Investigator Name
Daniela Rau
Principal Investigator Email
rau@neurologie-ulm.de
Contact Person Name
Daniela Rau
Contact Person Email
rau@neurologie-ulm.de
Site Name
University Of Regensburg
Department Name
Klinik und Poliklinik fuer Neurologie
Principal Investigator Name
Klemens Angstwurm
Principal Investigator Email
klemens.angstwurm@medbo.de
Contact Person Name
Klemens Angstwurm
Contact Person Email
klemens.angstwurm@medbo.de
Site Name
Studienzentrum Nord-West
Principal Investigator Name
Wolfgang Schwarz
Principal Investigator Email
wschwarz@studienzentrum-nordwest.de
Contact Person Name
Wolfgang Schwarz
Site Name
Zentrum fuer ambulante Neurologie
Department Name
Neurotransdata GmbH
Principal Investigator Name
Harald Landefeld
Principal Investigator Email
haraldlandefeld@web.de
Contact Person Name
Harald Landefeld
Contact Person Email
haraldlandefeld@web.de
Site Name
Klinikum Bayreuth GmbH
Department Name
Klinik fuer Neurologie
Principal Investigator Name
Patrick Oschmann
Principal Investigator Email
patrick.oschmann@klinikum-bayreuth.de
Contact Person Name
Patrick Oschmann

Netherlands

Earliest CTIS Part Ii Submission Date
20-06-2024
Latest Decision Or Authorization Date
08-07-2024
Processing Time Days
18
Number Of Sites
1
Number Of Participants
6

Sites

Site Name
Zuyderland Medisch Centrum Stichting
Department Name
Department of Neurology
Principal Investigator Name
Stephanie Knippenberg
Principal Investigator Email
s.knippenberg@zuyderland.nl
Contact Person Name
Stephanie Knippenberg
Contact Person Email
s.knippenberg@zuyderland.nl

Austria

Earliest CTIS Part Ii Submission Date
20-06-2024
Latest Decision Or Authorization Date
15-07-2024
Processing Time Days
25
Number Of Sites
3
Number Of Participants
10

Sites

Site Name
Konvent Der Barmherzigen Brueder
Department Name
Abteilung für Neurologie
Principal Investigator Name
Thomas Hofer
Principal Investigator Email
thomas.hofer@bblinz.at
Contact Person Name
Thomas Hofer
Contact Person Email
thomas.hofer@bblinz.at
Site Name
Medizinische Universitaet Innsbruck
Department Name
Universitätsklinik für Neurologie
Principal Investigator Name
Florian Deisenhammer
Principal Investigator Email
florian.deisenhammer@tirol-kliniken.at
Contact Person Name
Florian Deisenhammer
Site Name
Medical University Of Vienna
Department Name
Universitätsklinik für Neurologie
Principal Investigator Name
Walter Rinner
Principal Investigator Email
walter.rinner@meduniwien.ac.at
Contact Person Name
Walter Rinner
Contact Person Email
walter.rinner@meduniwien.ac.at

Sponsor

Primary sponsor

Full Name
F. Hoffmann-La Roche AG
Organisation Type
Pharmaceutical company
Country Of Registered Address
Switzerland

Contract research organisations

Name
Almac Clinical Technologies LLC
Responsibilities
sponsorDuties codes: ["3"]
Name
Labcorp Central Laboratory Services LP
Responsibilities
sponsorDuties codes: ["4"]
Name
Unilabs A/S
Responsibilities
sponsorDuties codes: ["4"]

Third parties

  • {"country":"Canada","full_name":"Neurorx Research Inc.","duties_or_roles":"sponsorDuties codes: [\"4\"]","organisation_type":"Pharmaceutical company"}
  • {"country":"Denmark","full_name":"Unilabs A/S","duties_or_roles":"sponsorDuties codes: [\"4\"]","organisation_type":"Laboratory/Research/Testing facility"}
  • {"country":"United States","full_name":"Almac Clinical Technologies LLC","duties_or_roles":"sponsorDuties codes: [\"3\"]","organisation_type":"Pharmaceutical company"}
  • {"country":"United States","full_name":"Labcorp Central Laboratory Services LP","duties_or_roles":"sponsorDuties codes: [\"4\"]","organisation_type":"Pharmaceutical company"}
  • {"country":"Switzerland","full_name":"Neurostatus-UHB AG","duties_or_roles":"EDSS licencing, EDSS e-test and training, EDSS score consultation","organisation_type":"Laboratory/Research/Testing facility"}

Investigational products

Investigational Product Name
Ocrevus 300 mg concentrate for solution for infusion
Active Substance
Ocrelizumab
Modality
Monoclonal antibody
Routes Of Administration
Intravenous infusion
Route
Intravenous infusion
Authorisation Status
Authorised (marketing authorisation number EU/1/17/1231/001)
Starting Dose
300 mg (product name indicates 300 mg concentrate for solution for infusion)
Maximum Dose
600 mg (maxDailyDoseAmount 600 mg)

Related trials

Other published trials that may interest you.